Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Business & Finance
Pharma company announces fourth quarter 2004 results
February 17th, 2005
Orphan Medical, Inc., (Nasdaq:ORPH) announced that 8,928 Xyrem prescriptions were filled during the fourth quarter, an increase of 9% from the 2004 third quarter and up 99% from the prior-year fourth quarter. The company filled a total of 28,537 prescriptions in 2004, an increase of 123% from 2003. John H. Bullion, chief executive officer, stated, "We are very pleased with the growth of Xyrem in 2004 and are excited about the potential for significant growth in the future. Prescription levels at year-end 2004 represent annualized revenues of approximately $15.0 million and we expect strong growth in new Xyrem prescriptions in 2005." ...
Source: Women's Health Weekly (2005-02-17)
|
